Abstract
Chlordiazepoxide (CDP 7.5 mg/kg) had a significant anxiolytic effect in rats tested on the plus-maze for the first time. On a second trial the control scores did not change, but those of the CDP group did and they no longer differed from controls. Rats previously tested undrugged or after flumazenil (4 mg/kg) also failed to show an anxiolytic response to CDP. Thus this phenomenon of one-trial tolerance depended on prior experience with the plus-maze. It also depended on CDP acting at the benzodiazepine receptors on trial 2, since the joint administration of CDP and flumazenil on trial 2 reversed the phenomenon.
This is a preview of subscription content, log in via an institution to check access.
References
File SE (1985) Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev 9:113–121
File SE, Baldwin HA (1989) Changes in anxiety in rats tolerant to, and withdrawn from, benzodiazepines: behavioural and biochemical studies. In: Tyrer P (ed) Psychopharmacology of anxiety. Oxford University Press, Oxford, pp 28–51
File SE, Baldwin HA, Aranko K (1987) Anxiogenic effects from benzodiazepine withdrawal are linked to the development of tolerance. Brain Res Bull 19:607–610
Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
File, S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100, 281–282 (1990). https://doi.org/10.1007/BF02244419
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244419